Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial.
Journal Information
Full Title: J Clin Virol
Abbreviation: J Clin Virol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of Competing Interest The authors declare that they have no conflicts of interest."
"Funding This work was supported by Medigen Vaccine Biologics Corporation (award number: XMRPG3L0101) and Chang Gung Memorial Hospital (award numbers: CORPG3K0311, CORPG3L0371, CORPG3L0481, and CORPG3K0242), Taiwan. The study was also supported in part by the Research Center for Epidemic Prevention Science, Chang Gung University (award number: MOST 109–2327-B-182–002), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Trial registrationClinicalTrials.gov NCT05132855."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025